Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D KERR

Showing results (271-280 of 633) with videos related to

Pageof 64
Sort By:
Peptides|November 26, 2008
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intoleranceBarry D Kerr, Nigel Irwin, Peter R Flatt, et al.
International Journal of Oncology|May 10, 2007
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugsSuebwong Chuthapisith, Robert Layfield, Ian D Kerr, et al.
Nature Communications|April 22, 2020
Impact of visual callosal pathway is dependent upon ipsilateral thalamusVishnudev Ramachandra, Verena Pawlak, Damian J Wallace, et al.
Scientific Reports|January 16, 2021
Benchtop micro-mashing: high-throughput, robust, experimental beer brewingEdward D Kerr, Christopher H Caboche, Peter Josh, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 12, 2019
A low cost, portable NMR probe for high pressure, MR relaxometryJulia D Kerr, Bruce J Balcom, Michael J McCarthy, et al.
Journal of Nematology|March 7, 2009
Host Suitability of Rapeseed for Heterodera schachtiiEric L Nielsen, David D Baltensperger, Eric D Kerr, et al.
Biochemical Pharmacology|March 23, 2013
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic propertiesVikas K Bhat, Barry D Kerr, Peter R Flatt, et al.
Aviation, Space, and Environmental Medicine|April 1, 1985
Fluid replacement during hypothermiaD E Roberts, J C Barr, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2003
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factorsS Cascinu, V Georgoulias, D Kerr, et al.
Expert Opinion on Drug Discovery|September 2, 2020
Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancerMatthew D Kerr, David A McBride, Arun K Chumber, et al.
Pageof 64

Showing results (271-280 of 633) with videos related to

Sort By:
Pageof 64
Peptides|November 26, 2008
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intoleranceBarry D Kerr, Nigel Irwin, Peter R Flatt, et al.
International Journal of Oncology|May 10, 2007
Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugsSuebwong Chuthapisith, Robert Layfield, Ian D Kerr, et al.
Nature Communications|April 22, 2020
Impact of visual callosal pathway is dependent upon ipsilateral thalamusVishnudev Ramachandra, Verena Pawlak, Damian J Wallace, et al.
Scientific Reports|January 16, 2021
Benchtop micro-mashing: high-throughput, robust, experimental beer brewingEdward D Kerr, Christopher H Caboche, Peter Josh, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|May 12, 2019
A low cost, portable NMR probe for high pressure, MR relaxometryJulia D Kerr, Bruce J Balcom, Michael J McCarthy, et al.
Journal of Nematology|March 7, 2009
Host Suitability of Rapeseed for Heterodera schachtiiEric L Nielsen, David D Baltensperger, Eric D Kerr, et al.
Biochemical Pharmacology|March 23, 2013
A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic propertiesVikas K Bhat, Barry D Kerr, Peter R Flatt, et al.
Aviation, Space, and Environmental Medicine|April 1, 1985
Fluid replacement during hypothermiaD E Roberts, J C Barr, D Kerr, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2003
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factorsS Cascinu, V Georgoulias, D Kerr, et al.
Expert Opinion on Drug Discovery|September 2, 2020
Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancerMatthew D Kerr, David A McBride, Arun K Chumber, et al.
Pageof 64